| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 343.99 | 6.8% | 15.7% |
| Total Income | 356.60 | 17.5% | 16.1% |
| Expenditure | 239.66 | 6.0% | 38.5% |
| PBT | 116.93 | 43.3% | 12.8% |
| Net Profit | 89.26 | 45.2% | 10.7% |
| OPM | 33.97% | 0.23pp | 12.26pp |
| NPM | 25.03% | 12.68pp | 7.49pp |
| EPS | 5.38 | 45.2% | 55.3% |
AUM at ₹1L+ Crore: Can Margins Hold as Costs Spike?
Anand Rathi reports Q2 results Oct 9 on the back of a stellar Q1 (PAT +24%, revenue +18%). The Street's debate now pivots to cost control—employee expenses jumped 67% last quarter, compressing margins to 7-quarter lows. Watch whether management can sustain guidance amid inflationary wage pressure.
The Print to Watch: Can Profitability Growth Survive Wage Inflation?
Anand Rathi Wealth has built a stunning growth trajectory—Q1 FY27 delivered PAT up 24% YoY to ₹116 crore on revenue growth of 18% to ₹336 crore, while AUM surged past the ₹1 lakh crore milestone. But the Street's focus for Q2 has narrowed to one number: the cost-income ratio. Employee expenses spiked 67% YoY in Q4 FY26, outpacing revenue growth and compressing operating margins to a 7-quarter low. Q2 will signal whether this is cyclical hiring or the beginning of structural margin pressure.
~₹360–380 Cr
Q1 was ₹336 Cr (+18% YoY); 20–25% guidance implies steady trajectory
~₹130–145 Cr
Q1 was ₹116 Cr (+24%); margins will reveal cost momentum
~20% YoY
Q1 grew 21% to ₹106,300 Cr; management guides 20–25% medium-term
Operating cost inflation
Employee costs +67% YoY in Q4; watch whether Q2 moderates or accelerates
A strong Q2 print means revenue and PAT both grow 20%+ YoY with margins holding steady (above 33%)—showing the company can scale hiring without sacrificing profitability. A weak print would show margins slipping below 32%, employee cost leverage negative, or AUM growth decelerating below 18%—any of which would suggest the wage pressure is structural, not cyclical, and threaten FY27 guidance.
On Track for Guidance?
Anand Rathi's management guides for 20–25% annual AUM growth over the next 3–4 years with 90–95% confidence, and FY27 full-year revenue is on course for similar expansion. Q1 traction (PAT +24%, AUM +21%) validates the playbook. But the cost base—especially employee costs—has inflated faster than revenue over the last two quarters, which the Street views as a test of management execution. If Q2 shows discipline (cost growth in-line with or below revenue growth), the guidance remains credible. If costs ramp again, the FY27 PAT target comes under threat despite strong AUM momentum.
Since Q1: Corporate Moves & Insider Activity
Oct 1, 2026
Standard pre-results window; closed Oct 1, re-opens 48 hrs post-result
Trading window closed
Sep 30, 2026
Oct 9: Board to approve Q2 & H1 results, consider dividend; no guidance yet
Board meeting intimation
Sep 2, 2026
₹5.49 Cr invested in Anand Rathi FME (IFSC) via rights issue; IFSCA approval pending
Subsidiary capital infusion
Aug–Jun 2026
Anand Rathi & family trusts acquired ~10L shares @ ₹1,975–₹3,458; buyback signal
Promoter/family buying via block deals
Jul 16, 2026
Anand Rathi FME (IFSC) got in-principle IFSCA approval for fund management
Subsidiary milestone
Jun 10, 2026
Promoter pledge
The insider/promoter activity over the past quarter has been modestly positive: block purchases by Anand Rathi (parent) and family trusts near ₹1,975–₹2,000 suggest confidence in valuation, though one large seller (Fahim Sultan Ali, ~7L shares in May near ₹3,458) took profit at higher levels. The subsidiary's IFSCA approval for fund management is strategic—it opens a new revenue stream in the GIFT City ecosystem. One modest red flag: Jun 10 encumbrance of 0.72% by the promoter parent (Anand Rathi Financial Services) to secure borrowing—worth monitoring for leverage trends.
1 · Operating margin trend
Q2 PAT margin vs Q1's 34.4%—will employee cost growth moderate or worsen? A margin below 32% would trigger selling and validate Street concerns. Target: Q2 margin ≥33%.
2 · AUM growth consistency
Is the 21% YoY AUM growth from Q1 sustaining into Q2? Slowdown below 18% YoY would suggest momentum fade; sustained 20%+ is a green flag for FY27 guidance.
3 · Dividend & FY27 guide reaffirmation
Board may declare interim dividend. Watch whether management reaffirms 20–25% AUM growth and 20%+ revenue CAGR for FY27, or signals caution on cost pressures.
Anand Rathi Wealth stands at an inflection: it has proved it can grow AUM past ₹1L crore and expand PAT at 20%+ rates, but wage inflation is forcing a test of operational discipline. Q2 results on Oct 9 will show whether the company can scale profitably or whether margin pressure is structural. The Street (consensus Hold, target ₹2,629) is essentially waiting for proof—strong numbers with stable margins could reignite a re-rating, while margin slippage or cost guidance raise would justify the recent Sep 29 downgrade. Promoter buying and subsidiary IFSCA approval provide some confidence, but execution is now the only number that matters.
Strong flows, soft profits — execution risk on new ventures
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
H1 pacing on track: 49% of revenue, 52% of PAT guidance delivered. Q1 implied ₹150 Cr PAT, Q2 ₹89 Cr shows sharp decline.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong AUM growth momentum (₹4.2B net flows, 39% YoY) and execution on new initiatives (AMC, GIFT, structured products) offset near-term PAT headwind: down 10.6% YoY despite 15.7% revenue growth, signaling margin compression from cost inflation and one-time ESOP charges. Guidance implied maintained but not reaffirmed; Q2 QoQ PAT decline of 45.2% raises H2 visibility concerns.
₹344 Cr
Revenue · +15.7% YoY₹89.3 Cr
Reported PAT · −10.6% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
PAT grew 23% YoY after tax adjustments
OVERSTATEDReported PAT ₹89.3 Cr down 10.6% YoY; adjusted PAT (excl. ₹46 Cr non-cash charges) ~₹135 Cr implies ~25% growth but this is non-GAAP
Revenue increased 17% YoY
OVERSTATEDDelivered ₹344 Cr, 15.7% YoY growth
Highest net flow ever, ₹4,186 Cr, up 39% YoY
METSupports strong AUM momentum; unverified independently but plausible given client acquisition metrics
49% of FY27 revenue guidance penetration in H1
METIf ₹1,415 Cr full-year guidance, 49% = ₹693 Cr for H1; aligns with stated ~₹357 Cr for first half
Earnings quality
What changed since the last call
ESOP and mark-to-market charges materialized
DowngradeQ2 saw ₹46 Cr one-time charges vs. zero in Q2 FY26; management claimed this would reduce next year but provided no forecast.
Structured products strategy clarified
NewFeroze spent heavily detailing MLD issuances (₹2.8B total) and back-testing (94% win rate), but no revenue or margin contribution disclosed; perceived as future growth engine, not current.
Near-term PAT growth concern flagged
DowngradeManagement stated 20-25% PAT growth as a concern threshold if not met; Q2 actual -10.6% YoY triggers this concern. Prior call implied full-year 25% PAT guidance; now hedged.
AUM target refined
Maintained₹1.2L Cr FY27 target reiterated; net flow guidance narrowed to ₹6,000-₹8,000 Cr with 2-3% mark-to-market as most volatile component.
The Q&A
Analysts pressed hard on 20-25% PAT growth sustainability (Prayesh Jain), UHNI yield parity (Shreink Mehta), MLD complexity (Jyoti Khatri), cost trajectory (Sucrit Patil), and capacity constraints (Sanil). Feroze answered directly on most, though MLD explanation was lengthy/technical. Defensive tone on near-term but did not capitulate on strategy.
PAT growth outlook — Prayesh Jain, Motilal Oswal
PartialNo. Near-term slowdown is normal; we rely on RM talent and market conditions. Mistakes happen. Long-term thesis unchanged.
UHNI wallet concentration — Shreink Mehta, IndoAsia
AnsweredTop 100 clients represent >50% of platinum wallet. Yield marginally better, not premium. Economies of scale add value-adds, not fee discounts.
Execution priorities — Sucrit Patil, Eyesight Fintrack
AnsweredFour engines: (1) client performance (12% target), (2) capacity utilization (431 RMs, can handle 8,000 more), (3) new plant/machinery (500 new RMs identified, being trained), (4) wallet penetration (deliver 5-6% Jensen's Alpha).
Non-cash charges — Milind Kulkarni, MLDL
Answered₹46 Cr is ESOP and mark-to-market; Q2 FY26 was zero. Will reduce next year but timeline not specified.
AUM growth breakdown — Arun Gopal, Retiree
AnsweredTarget ₹1.2L Cr AUM for FY27. Net flow guidance ₹6,000-₹8,000 Cr. Mark-to-market 2-3% guidance, most volatile. Nifty down 5% last quarter cost ₹2,000 Cr in mark-to-market.
Structured products (MLDs) — Jyoti Khatri, Ambit Wealth
AnsweredStructured products require NBFC with derivative hedging. Back-tested 94% success. Longest win streak 1,190 products (Dec 2020–May 2026). Embedded derivatives, delta-hedged. Design uses Monte Carlo simulator with 90% target outcomes.
GIFT City revenue opportunity — Nikhil Agarwal, Choice International
PartialIndia-centric organization. Will deliver Indian resident proposition as well as NRI-focused tax-efficient structured products. Will not count eggs today; proof of concept required before revenue targets.
AMC license timeline — Sunil Shah, SRE PMS
AnsweredApplied month-end October; expect filing by 20th October. Almost all data prepared. Expect good news by January 2027 results (Q3 FY27).
Guidance
FY27 full-year ₹1,415 Cr (implied from 49% H1 penetration)
HighH1 shows 49% delivery; aligned with ₹357 Cr stated revenue for first half. Requires ~₹722 Cr H2, or 9% QoQ growth; achievable given 6.8% Q2 QoQ pace.
PAT ₹460 Cr for FY27 (implied); OPM maintained 34%+, NPM 25%+
MediumH1 PAT implied ~₹239 Cr (52% of ₹460 Cr). Requires ~₹221 Cr H2 PAT, or 40.9% of full-year. Q2 decline to ₹89 Cr suggests cost/charge pressure; management claims ESOP will reduce.
Risks the call surfaced
Market volatility & AUM dependency
MediumMark-to-market guidance 2-3% is most volatile AUM component. Nifty down 5% in Q2 cost ₹2B in AUM. Guidance tied to ₹1.2L Cr AUM target dependent on stable/positive market.
Cost inflation & margin compression
HighESOP charges ₹46 Cr in Q2 (zero in Q2 FY26) impacted PAT. QoQ PAT down 45.2% despite 6.8% revenue growth. Employee cost inflation cited as ongoing headwind; trajectory unclear.
Structured products & regulatory complexity
MediumStructured products (MLDs) strategy heavily touted (30% of call time) but unproven on revenue/profitability. Products are highly leveraged with embedded derivatives; client education and regulatory acceptance key. Back-testing success (94%) does not guarantee market acceptance.
Capacity constraints & RM bottleneck
MediumManagement identified 500 new relationship managers (RMs) needed; capacity currently 431 RMs handling 8,000+ client families. Slow RM ramp could bottleneck new client acquisitions and wallet expansion.
New venture execution risk
MediumThree new initiatives (AMC license filing, GIFT City, UK operations) are early-stage. AMC license approval timeline uncertain (expected Q3 FY27). GIFT City and UK are greenfield; profitability/timeline unquantified.
Management
Score 7/10. Direct on strategy and mechanics; answered most Q&A questions with specificity. Long-winded on structured products (30 min+); occasional deflection on near-term PAT guidance. Strong track record: 20 quarters of PAT growth >20% since listing (Dec 2021). H1 FY27 on track (49% revenue, 52% PAT penetration). Q2 QoQ PAT decline (-45.2%) signals execution headwind, but attributed to one-time charges.
1 · Oct 2026
AMC license filing expected to complete; regulatory approval timeline TBD
2 · H2 FY27
GIFT City operations launch in India; London UK subsidiary ramp
3 · Jan 2027
Q3 FY27 results; management signals 'good news' on AMC approval expected by then
Guidance implied maintained but not reaffirmed; Q2 QoQ PAT decline of 45.2% raises H2 visibility concerns.
Record net flows mask margin compression from cost inflation and one-time charges
Anand Rathi landed record ₹4,186 crore in net flows and grew revenue 15.7% YoY, but reported profit fell 10.6% YoY due to ₹46 crore in one-time charges. Adjusted for these, profit is up 25% — but the QoQ profit collapse of 45.2% despite 6.8% revenue growth reveals the real story: cost inflation is eating into gains.
₹89.3 Cr
-10.6% YoY
~₹135 Cr
+25% YoY (excl. ₹46 Cr)
₹4,186 Cr
Highest in 20 years
₹344 Cr
+15.7% YoY, +6.8% QoQ
-45.2%
From ~₹163 Cr (Q1)
~₹1.08L Cr
Target ₹1.2L Cr FY27
The headline tension is stark: revenue and flows are accelerating, but profit is decelerating. Anand Rathi landed its largest quarterly net inflow (₹4,186 crore, up 39% YoY) and grew revenue 15.7% year-on-year. Yet reported profit fell 10.6% despite the topline push. The culprit is not demand or client quality — it's cost. The quarter carried ₹46 crore in one-time charges (ESOP grants and mark-to-market losses, vs. zero in the prior-year quarter), which if added back would show a 25% profit growth. But that's the non-GAAP read. The reported number is what matters for taxation and shareholder value, and it's down. More concerning: profit fell 45.2% sequentially despite revenue growing 6.8% QoQ — a sign that cost inflation is outrunning pricing power, and the one-time charge story may be a convenient framing of a deeper margin squeeze.
Reported vs. adjusted profit — where the gap comes from
Revenue increased 17% YoY
₹344 Cr, 15.7% YoY growth
Slightly overstated
Highest net flow ever, ₹4,186 Cr, up 39% YoY
Confirmed; highest in company's 20-year history
Supported
49% of FY27 revenue guidance penetration in H1
H1 ~₹357 Cr; aligns with implied ₹1,415 Cr full-year
Supported
20-25% PAT growth expected for near-term
Q2 PAT -10.6% YoY reported; adjusted +25% but not reported headline
Overstated (as reported)
What changed on this call
Four material shifts from the prior Q1 call: (1) ESOP charges materialized. Management flagged cost inflation in Q1; Q2 saw ₹46 crore in ESOP and mark-to-market expenses hit the P&L vs. zero in Q2 FY26. They claim this will decline next year but offered no quantified forecast, raising visibility concerns. (2) Structured products strategy clarified. Management spent 30% of call time detailing MLD (Market-Linked Debenture) issuances: ₹2,100 crore primary, ₹750 crore secondary in Q2, with 94% back-tested win rate. These are positioned as a future profit engine, but revenue contribution is unquantified. (3) Near-term PAT growth concern flagged. Management flagged 20-25% PAT growth as a concern threshold if not met. Q2 delivery (-10.6% YoY) falls well short, triggering the concern. Prior Q1 call implied full-year 25% PAT guidance; now hedged. (4) AUM target refined. ₹1.2L Cr (₹1,20,000 Cr) FY27 target reaffirmed; net flow guidance narrowed to ₹6,000-₹8,000 Cr with 2-3% mark-to-market cited as most volatile.
Highest net flows in 20 years (₹4,186 Cr, +39% YoY)
1,500 new client families in 12 months; 0.17% attrition
Revenue growth 15.7% YoY despite market volatility
Adjusted PAT +25% YoY (excl. one-time charges)
Reported PAT down 10.6% YoY (margin compression)
QoQ profit collapsed 45.2% despite revenue +6.8%
ESOP charges ₹46 Cr (zero in prior-year quarter)
Structured products unquantified on revenue contribution
RM capacity constraints may limit near-term growth
Cost inflation outpacing revenue growth; margin compression visible in QoQ decline
HighQ2 QoQ profit fell 45.2% despite 6.8% revenue growth. ESOP charges are real. If core cost inflation persists, reported profit growth will remain pressured. Guidance (₹460 Cr PAT for FY27) is at risk if H2 sees further one-time charges or wage inflation.
Mark-to-market AUM volatility; guidance dependent on stable/positive markets
MediumManagement cites 2-3% mark-to-market as most volatile AUM component. Nifty down 5% in Q2 cost ₹2,000 Cr in AUM. ₹1.2L Cr FY27 target assumes positive markets. Market downturn could force a miss.
Structured products unproven on revenue and client adoption
MediumManagement spent 30% of call on MLDs (₹2,800 Cr issuances) but disclosed zero revenue contribution. Products are highly leveraged — regulatory risk and client education burden are real. If adoption disappoints, this 'future engine' becomes a distraction.
RM capacity constraints bottlenecking growth
MediumManagement identified 500 new RMs needed but training is ongoing. Current 431 RMs suggest capacity for 8,000+ more clients. Slow RM ramp could limit net client acquisitions despite strong flow momentum.
AMC license and GIFT City execution unproven; timing uncertain
MediumAMC license application expected by Oct 2026; approval timeline unspecified. GIFT City and UK operations are early-stage with zero revenue. Capital allocation and management distraction are risks if execution lags.
How the street is positioned
The market's initial reaction was favourable and the pop held through day 3. The day-1 pop was +2.37%, building to +3.85% by day 3 after the Oct 9 announcement, suggesting the market liked the flows story and strong AUM momentum. Current price ₹2,142.6 is up approximately +5% from the pre-result close of ₹2,038.7, indicating the reaction extended further. However, the stock is now -5.55% off its all-time high of ₹2,268.4 and trading below its SMA50 (₹2,163.05), a neutral-to-cautious setup. RSI at 46.9 is neutral. The institutional bid remains intact: FII ownership increased +0.59 percentage points QoQ to 6.37%, and DII increased +1.29 pp to 10.39%, suggesting institutional support despite the near-term margin headwinds. Insider activity shows nuance: recent block deals at ₹1,975 show fresh buying interest (Hemang Shah Family Trust, K R Family Trust, Manjushree Fincap), but in May there were larger promoter-linked sales near the highs (Anand Rathi Financial Services sold 14.46 lakh shares at ₹3,457.97; Fahim Sultan Ali sold 5.08 lakh shares at ₹3,484.96). That suggests early insiders took profits at the peak. The -5.55% drawdown from ATH combined with the institutional nibbling suggests the market is pricing the flows story and optionality from new ventures, while discounting the near-term profit headwinds. This aligns with the fundamental read: strong flows are real, but margin compression is the current reality.
1 · H2 cost trajectory and ESOP decline
Management claims ESOP charges will decline next year but gave no quantified forecast. Q3 results (Jan 2027) will show whether Q2's ₹46 Cr charge was a true one-time or the start of sustained cost pressure. If adjusted PAT remains flat or declines QoQ, the margin story deteriorates.
2 · AMC license approval by Jan 2027
Management flagged 'good news' on the mutual fund license by Q3 FY27 results. Approval would unlock a new revenue stream and validate the four-engine growth thesis. Delay would miss and pressure sentiment.
3 · RM hiring and capacity utilization
Watch for updates on the 500 new RM hires and their ramp. If new RM productivity lags or attrition rises, that signals cost inflation is beginning to impact hire quality or retention — compounding near-term profit pressure.
4 · Market conditions and AUM mark-to-market impact
Nifty down 5% cost ₹2,000 Cr in Q2. FY27 AUM target (₹1.2L Cr) assumes positive or flat markets. A sustained downturn could force a miss, and near-term flows may not offset mark-to-market headwinds.
Anand Rathi remains a high-quality franchise with exceptional client acquisition momentum and low attrition. The ₹4,186 crore in net flows is genuinely impressive and speaks to brand and service differentiation. But this quarter proved a hard reality: flows do not translate 1:1 into profit. Cost inflation is real, ESOP charges hit the P&L, and margins are compressing despite revenue growth. The adjusted PAT number (up 25%) is reassuring on a non-GAAP basis, but reported profit (down 10.6%) is what shareholders care about.
The hold rating is warranted — neither a clear buy on the flows story nor a clear sell on the margin headwinds. The debate turns entirely on execution: can management stabilize reported profit margins in H2 by controlling costs, or will cost inflation persist? Can the AMC license, GIFT City, and structured products come through before flow momentum exhausts itself? The single number to track from here is reported PAT in Q3. If it shows sequential growth with cost moderation, the H2 guidance becomes credible. If it declines again, the AUM thesis alone will not carry the stock.